ROBERT CONWAY Insider Trading $ALPN ALPINE IMMUNE SCIENCES, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ROBERT CONWAY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT CONWAY. ROBERT CONWAY is Director in ARCA biopharma, Inc. ($ABIO) and CEO in ARRAY BIOPHARMA INC ($ARRY) and CHIEF EXECUTIVE OFFICER in ARRAY BIOPHARMA INC ($ARRY) and Director in Nivalis Therapeutics, Inc. ($NVLS).
ROBERT CONWAY in ALPINE IMMUNE SCIENCES, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT CONWAY: Director
Holdings: 25,000 shares
Current Value: $58,500
Latest Transaction: Nov 23 2020
$ALPN Market Capitalization: $36.22M
$ALPN Previous Close: $2.34
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ROBERT CONWAY in ALPINE IMMUNE SCIENCES, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALPN, ABIO, ARRY
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 23 2020 | ALPN | ALPINE IMMUNE SCIE ... | CONWAY ROBERT E | Director | Buy | P | 8.03 | 10,000 | 80,300 | 25,000 | 15 K to 25 K (+66.67 %) |
| Jan 06 2020 | ALPN | ALPINE IMMUNE SCIE ... | CONWAY ROBERT E | Director | Option Exercise | A | 3.62 | 7,650 | 27,718 | 7,650 | |
| Jan 04 2019 | ALPN | ALPINE IMMUNE SCIE ... | CONWAY ROBERT E | Director | Option Exercise | A | 4.09 | 7,650 | 31,289 | 7,650 | |
| Jan 04 2018 | NVLS | ALPINE IMMUNE SCIE ... | CONWAY ROBERT E | Director | Option Exercise | A | 11.31 | 7,650 | 86,522 | 7,650 | |
| May 11 2017 | NVLS | Nivalis Therapeuti ... | CONWAY ROBERT E | Director | Buy | P | 2.28 | 15,000 | 34,200 | 60,000 | 45 K to 60 K (+33.33 %) |
| May 10 2017 | NVLS | Nivalis Therapeuti ... | CONWAY ROBERT E | Director | Buy | P | 2.34 | 5,000 | 11,700 | 45,000 | 40 K to 45 K (+12.50 %) |
| May 09 2017 | NVLS | Nivalis Therapeuti ... | CONWAY ROBERT E | Director | Buy | P | 2.30 | 20,000 | 46,000 | 40,000 | 20 K to 40 K (+100.00 %) |
| May 08 2017 | NVLS | Nivalis Therapeuti ... | CONWAY ROBERT E | Director | Buy | P | 2.26 | 10,000 | 22,600 | 20,000 | 10 K to 20 K (+100.00 %) |
| Sep 14 2016 | NVLS | Nivalis Therapeuti ... | CONWAY ROBERT E | Director | Option Exercise | A | 7.77 | 12,300 | 95,571 | 12,300 | |
| Dec 11 2015 | NVLS | Nivalis Therapeuti ... | CONWAY ROBERT E | Director | Buy | P | 8.10 | 10,000 | 81,000 | 10,000 | 0 to 10 K |
| Sep 15 2015 | NVLS | Nivalis Therapeuti ... | CONWAY ROBERT E | Director | Option Exercise | A | 15.28 | 7,650 | 116,892 | 7,650 | |
| Jul 20 2015 | NVLS | Nivalis Therapeuti ... | CONWAY ROBERT E | Director | Option Exercise | A | 17.49 | 11,475 | 200,698 | 11,475 |
Page: 1